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Abstract 
 
Porous calcium phosphate ceramics (mainly hydroxyapatite) with interconnected macropores (~ 1 
mm) and micropores (~ 5 μm) as well as high porosities (~ 80%) were prepared by firing 
polyurethane foams that were coated with calcium phosphate cement at 1200 oC. In order to 
improve the mechanical properties such as compressive strength and compressive modulus and 
maintain the desirable bioactivity (i.e. the ability of apatite layer formation), the open micropores of 
the struts were infiltrated with poly(lactic-co-glycolic acid) (PLGA) to achieve an interpenetrating 
bioactive ceramic/ biodegradable polymer composite structure. The PLGA filled struts were further 
coated with a 58S bioactive glass (33wt%)-PLGA composite coating. The PLGA- bioactive glass 
modified porous calcium phosphate ceramics proved to be bioactive and exhibited compressive 
strengths up to 7.7 MPa and compressive moduli up to 3 GPa, which were comparable to those of 
natural spongy bones. The obtained complex porous bioactive/ biodegradable composites could be 
used as tissue engineering scaffolds for low-load bearing applications. 
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1. Introduction 
 
Porous biomaterials have proved to be important for bone replacement and regeneration. Many 
porous polymers and porous ceramics have been prepared for orthopedic applications. Porous 
titanium (Ti), tantalum (Ta) [1], and magnesium (biodegradable) [2] are also used as scaffolds for 
bone tissue engineering. A trend for scaffold materials is the development of compositionally and 
geometrically complex scaffolds to meet the strict property requirements. For instance, there are 
intensive studies on the surface-modified scaffolds, nano-composite scaffolds, and hybrid scaffolds. 
Some scaffolds are also modified with drugs, growth factors, and proteins, etc. 
 
Specifically for porous bioceramics, tens of methods have been developed for the scaffold 
preparation. For example, Charriere et al. [3] successfully built precipitated hydroxyapatite cement 
scaffolds with controlled macropore size and shape using a solid freeform fabrication process. The 
current author [4] also produced porous calcium phosphate ceramics through the usage of calcium 
phosphate cement, which was coated on combustible polyurethane foams. Individually developed 
methods can also be combined to obtain better porous structures and mechanical properties. For 
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example, Li et al. [5] combined a foaming method and a dual-phase mixing method (involving HA 
slurry and polymethylmethacrylate (PMMA) resin) to prepare macroporous hydroxyapatite (HA). 
Similarly, Ramay et al. [6] used a technique that combined a gel-casting method with a polymer 
sponge method to prepare macroporous hydroxyapatite scaffolds. 
 
While porous bioactive and/ or biodegradable ceramics are highly biocompatible, osteoconductive, 
and even osteoinductive, their mechanical properties such as fracture toughness and compressive 
strength are very poor especially when the porosities are high. To avoid the brittleness of porous 
ceramics, many porous biodegradable polymer / bioactive (or biodegradable) ceramic composite 
systems have been developed. For example, Maquet et al.  [7] prepared highly porous poly(D,L-
lactide)/ Bioglass composite scaffolds by a thermally induced phase separation process and by 
subsequent solvent sublimation. Lu  et al. [8] also developed a three dimensional (3-D), porous 
composite of polylactide-co-glycolide (PLGA) and 45S5 bioactive glass for bone tissue 
engineering.  
 
It should be mentioned that the above polymer/ ceramic composites were polymer matrix-based 
composites with dispersed ceramic phases. The amount of the ceramic phase was often limited by 
the processing method used. The bioactivity of a dispersed composite may not be maximized due to 
the isolation of the ceramic particles by the polymer matrix. In order to overcome these 
shortcomings of the randomly dispersed composites, one may need to develop interpenetrating 
ceramic/ polymer composites. For example, Li et al. [9] produced macroporous HA ceramics with 
struts of interconnected nanopores. Then a polymer phase, PolyactiveTM, was incorporated into the 
struts by vacuum impregnation. As a result, the mechanical properties of the porous composites 
with the interpenetrating organic/inorganic phases were found to improve significantly. 
 
Another way of using the advantages and minimizing the problems of porous bioactive/ 
biodegradable scaffolds could be the usage of a bioactive polymer coating or a biodegradable 
polymer/ bioactive ceramic composite coating. For example, Kim et al. [10] coated hydroxyapatite 
(HA) porous scaffolds with an HA and polycaprolactone (PCL) composite coating. The PCL 
polymer, as a coating component, was able to improve the brittleness and low strength of the HA 
scaffolds. The HA particles in the coating were to improve the osteoconductivity and bioactivity of 
the coating layer. 
 
In the present study, porous calcium phosphate (mainly hydroxyapatite) ceramics with both open 
macropores and micropores were prepared by sintering calcium phosphate cement that was coated 
on polyurethane foams. Bioactive glass–PLGA slurry was used to infiltrate the micropores in the 
struts and also coat the struts in order to improve the mechanical properties of the complex scaffolds 
without a loss of the bioactivity. While inspired by Kim et al.’s work, the present study differed 
from Kim et al.’s work in several aspects: our microporous calcium phosphate struts versus Kim et 
al.’s dense HA struts; our bioactive glass–PLGA coating versus Kim et al.’s HA-PCL coating; our 
higher compressive strength versus Kim et al.’s low strength due to the introduction of 
interpenetrating ceramic/ polymer struts. 
 
 
2. Experimental procedure 
 
2.1  Sample preparation 
 
Preparation of TTCP powder 
Pyro-calcium phosphate (Ca2P2O7) powder was mixed with calcium carbonate (CaCO3) powder in 
the weight ratio of 1.27: 1. For the mixing step, the starting powders were poured into an ethanol 
solution to produce a viscous paste. Then the mixed powder was dried and crushed using a mortar 
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and a pestle, followed by calcination in a platinum crucible at 1350°C for 5 hours in air and 
quenching in air to 25°C. Finally the calcined powder (TTCP phase) was ground into a fine powder. 
The chemical reaction for the TTCP powder was as follows: 
Ca2P2O7 + 2CaCO3            Æ      Ca4(PO4)2O (TTCP) + 2CO2                                                          (1) 
 
Preparation of TTCP-DCPA mixed powder 
The weight ratio of tetracalcium phosphate (Ca4(PO4)2O; TTCP)  powder to dicalcium phosphate 
anhydrous (CaHPO4; DCPA) powder was 72.9: 27.1. These powders were mixed in dry state in a 
jar placed in a vibration mill (SPEX 8000). The mixed powder was used to prepare calcium 
phosphate cement (CPC) by setting according to the following reaction:  
2Ca4(PO4)2 (TTCP)  +  2CaHPO4 (DCPA)     Æ         Ca10(PO4)6(OH)2  (HA)                      (2)     
 
Preparation of porous CPC using polyurethane foams 
First 0.5M Na2HPO4 was added into 1 liter of distilled water to produce Na2HPO4 aqueous solution, 
which was used as the liquid phase for the CPC. Then a flowable slurry for the CPC was obtained 
by mixing the liquid phase with the solid phase (i.e. the mixed powder mentioned above) in a ratio 
of 0.5ml:1g. This slurry was then used to coat the polyurethane foams of different pore sizes (2.3 
mm, 1.6 mm, and 1 mm) through the actions of slurry dipping, squeezing, and blowing with air. 
The slurry-coated foams were then allowed to set (i.e., reaction (2) occurred in the presence of the 
liquid phase) and dry to produce a porous CPC. 
 
Preparation of porous calcium phosphate ceramics (major hydroxyapatite) 
To remove the polyurethane foams, the coated foams were fired in air in an electric furnace using a 
4 stage schedule, which included (i) heating from 40ºC to 600ºC with a heating rate of 1ºC/ min (to 
burn off the polyurethane), (ii) further heating from 600ºC to 1200ºC at 5ºC /min., (iii) dwelling at 
1200oC for 2 hours (to partially sinter the CPC), and (iv) finally cooling  down to 40ºC at the 
cooling rate of 5ºC/ min.  
 
Preparation of 58S bioactive glass powder 
A sol-gel derived bioactive glass (coded as 58S) powder with particle sizes < 3 μm and of a 
composition of 58 mol% SiO2 – 38 mol% CaO – 4 mol% P2O5 was prepared through the hydrolysis 
and condensation of a mixed solution of tetraethoxysilane (TEOS; Si(OC2H5)4), triethylphosphate 
(TEP; OP(OC2H5)3) and calcium nitrate tetra-hydrate (Ca(NO3)2.4H2O). An HCl solution was used 
as a catalyst for the hydrolysis and condensation reactions. The formed sol was then sealed in a 
beaker and aged in an oven at 60ºC for 2 days. The formed gel was then dried in the oven at 60ºC 
for another 2 days. The dried gel after crushing was further calcined at 700ºC for 1 hour, followed 
by ball milling to obtain the 58S bioactive glass powder. 
 
Preparation of bioactive glass-PLGA coating on porous calcium phosphate ceramics 
Firstly, every 5g of 58S bioactive glass powder was mixed with 25ml of dichloromethane (CH2Cl2) 
solvent using a mortar and a pestle to disperse the fine glass particles. Secondly, the bioactive glass 
slurry was diluted with 45ml more of dichloromethane. Thirdly, 10g of PLGA (75LA: 25GA) was 
added so that the PLGA was dissolved completely. Lastly, the resulting flowable slurry was used to 
coat the sintered porous CPC through the actions of dipping, shaking, blowing, and evacuation.  
 
Biomimetic apatite coating on the bioactive glass-PLGA coated porous samples 
The bioactive glass-PLGA coated porous samples were immersed separately in glass containers that 
contained a simulated body fluid (SBF; the standard composition), and placed in an oven at a 
temperature of 37ºC for 1 to 2 weeks. After the immersion testing, the samples were taken out, 
rinsed with distilled water, and dried for subsequent surface examination. 
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2.2. Sample characterization 
 
Porosity measurement 
The total porosity of each sintered porous CPC sample was determined using the following 
equations: bulk density (ρB) = weight of the sample/ volume of the sample; the theoretical density for 
HA (ρo) = 3.16g/cm2; relative density (R.D.) = (ρB  / ρo) x 100%; and finally total porosity = 100 % 
– R.D. The dimensions and the weight of each sample were measured and recorded through a 
Vernier caliper and an electronic balance, respectively. 
 
Optical microscopy 
The overall morphologies (pore sizes and shapes) of the porous PU foams, the sintered porous CPC, 
and the bioactive glass-PLGA coated porous samples, were observed using a stero-optical 
microscope (Leics MZ6).  
 
X-ray diffraction (XRD) 
XRD was used to identify the crystallographic phases of the reaction products such as the TTCP 
powder, the set CPC, and the sintered CPC. For the XRD analysis, the samples were ground into 
fine powders and each powder was mounted in a specimen holder for the diffractometer (6000 
Shimadzu). Cu Kα1 ray (λ = 1.5406 Å) scanning was conducted using a 2θ angle of from 20° to 45°. 
The scan rate and the step size were 2.0° min-1 and 0.02°, respectively. 
 
SEM /EDS examination 
The topographical images of the sample surfaces or the fracture surfaces were examined under a 
JEOL 5310 scanning electron microscope (SEM). In addition, the elements present in the samples, 
especially in the top layers, were analyzed using energy dispersive spectroscopy (EDS). 
 
Compressive tests 
For the measurements of the compressive strengths of the porous samples (i.e. the porous sintered 
CPC and the bioactive glass-PLGA coated porous sintered CPC), rubber pads were placed on the 
top and the bottom surfaces of each sample. The rubber-padded sample was then placed in an 
Instron tester (model 5567) to conduct a compressive test. The rubber pads were used to ensure a 
uniform distribution of the applied load onto the sample. A crosshead speed of 0.5mm/min. was 
used for the compressive tests. 
 
 
3.  Results and discussion 
 
The commercially available polyurethane (PU) foams used for the study had high porosities, highly 
interconnected pores, and different pore sizes. Fig. 1 shows the PU foam with a pore size of 1 mm, 
as an example. When the foams were immersed in the CPC slurry, the ceramic particles carried by 
the aqueous solution were able to coat the struts of the PU foams. The excess ceramic slurry in the 
macropores must be driven away by hand squeezing, rolling with a roller, blowing with low 
pressure air, or centrifugation to prevent the blockage of the macropores by the ceramic slurry. 
Since the CPC slurry was made of TTCP and DCPA mixed powder plus the Na2HPO4 solution, the 
coating process should be completed before the setting reaction (i.e. the reaction between TTCP and 
DCPA in the presence of Na2HPO4 to form poorly crystallized hydroxyapatite). After the setting 
reaction, the slurry-coated PU foams could be dried in air at the room temperature. The setting 
reaction to form the hydroxyapatite phase made the CPC framework strong enough to stand freely 
without being sagged or distorted by the weight.  
 
Due to the lack of biocompatibility, the commercial PU foams must be removed by slow burning in 
air. The PU foams were thus used only as a template to form the ceramic framework. During the 
firing step, the struts of the PU foams experienced thermal expansion, melting, and evaporation. 
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Since the ceramic particles were joined together due to the setting reaction, the CPC framework 
would not be damaged by the removal of the PU, resulting in intact hydroxyapatite porous bodies. 
For example, Fig. 2 shows a sintered porous CPC body with a macropore size of 0.7 mm. On the 
other hand, the firing process would also change the microstructure of the set CPC. Specifically, in 
the set CPC, while the hydroxyapatite phase was present in the form of whiskers, as reported before 
[4], some residual TTCP and DCPA were still left behind. The set CPC was also porous with a large 
amount of micropores. Nevertheless, after sintering at 1200 oC for 2 hours, equal-axed 
hydroxyapatite grains were formed although microporosity remained in the struts (Fig. 3). In 
addition, the residual TTCP phase was depleted to a great extent for the formation of 
hydroxyapatite. Some β-TCP was also found in the sintered CPC, indicating some degree of 
thermal decomposition of the hydroxyapatite phase into the tricalcium phosphate phase, as shown in 
Fig. 4. Another feature of the sintered porous CPC was the presence of large defects (pores) inside 
the struts, which were due to the removal of the struts of the PU foams. Thus, the sintered porous 
CPC contained mainly hydroxyapatite phase with macropores (as a replica of the macropores in the 
PU foams) in the overall structure and open micropores in the struts.  
 
The sintered porous CPC was rather weak mechanically due to the high porosity and due to the 
intrinsically low mechanical strengths of the calcium phosphates. One way to strengthen and 
toughen the porous CPC was to infiltrate the microporous struts with a bioactive polymer, and also 
coat the struts with a bioactive polymer. However, a bioactive polymer was not available for the 
project, but a biodegradable polymer of PLGA was used instead. Since PLGA is not bioactive, thus 
PLGA coating must be made bioactive by incorporating a bioactive second phase. Since bioactive 
glass is known to be more bioactive than hydroxyapatite, thus a PLGA solution containing 
dispersed bioactive glass particles was used to infiltrate and coat the sintered porous CPC, as shown 
in Fig. 5. Several factors affected the coating process, namely, the viscosity of the slurry, the 
content of the bioactive glass fine particles, and the volatility of the organic solvent. The coating 
quality was also controlled by the details involved in the dipping coating process.  
 
Since the struts of the sintered porous CPC contained micropores that were open or interconnected, 
as shown in Fig. 3, the PLGA and some fine bioactive glass particles were able to penetrate into the 
open pores. As a result, a ceramic/ polymer composite of the interpenetrating phases was formed for 
the struts, as shown in Fig. 6. The significance of the interpenetrating composite can be seen from 
two aspects: Firstly, the composite was better than the pure porous sintered CPC due to the better 
mechanical integrity of the composite. In fact, several studies have indicated the strengthening and 
toughening effect in the interpenetrating composites. For example, Pezzotti et al. [11] prepared 
hydroxyapatite/ polymer interpenetrating composites and found that the high toughness of the 
composites was mainly due to a micron-scale crack-bridging mechanism operated by the polymer 
ligaments that were stretched upon crack opening along the crack wake. Secondly, a pure porous 
PLGA alone is mechanically weak and non-bioactive and subjects to change of shape and pH value 
in vivo. As to the interpenetrating composite, the pH change due to the biodegradation of PLGA 
would be mitigated and the distortion of the PLGA framework would be restricted by the relatively 
biostable porous hydroxyapatite framework.  
 
The dipping of the sintered porous CPC into the PLGA-bioactive glass slurry also resulted in a layer 
containing a PLGA matrix and the bioactive glass particles on the surface of the struts of the 
sintered porous CPC. The thickness of the coating layer could be controlled by number of the 
repeated dipping cycles. Due to a filtering effect of the micropores of the struts, larger bioactive 
glass particles were blocked and deposited on the surface of the struts. On the other hand, the 
evaporation of the solvent in the PLGA slurry resulted in a mesh-like or honeycomb-like structure. 
Thus a large number of bioactive glass particles were found exposed (Fig. 7), which was 
advantageous as far as bioactivity was concerned. The bioactivity of the bioactive glass was indeed 
confirmed after the immersion test using the simulated body fluid. Fig. 8 shows an apatite layer 
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formed on the PLGA-bioactive glass coating on the sintered porous CPC. The cracks observed in 
the apatite layer were common and were due to the poor interfacial bonding between the polymer 
and the apatite coating and due to the plastic deformation of the polymer layer occurring during the 
sample preparation. It should be mentioned that the apatite layer was confirmed after analysis with 
EDS, which indicated a right intensity ratio of the Ca peak to the P peak. 
 
The present study led to a new method of preparing porous calcium phosphate ceramics. The 
advantage of the method was the attainment of a high pore interconnectivity and a high porosity. 
The successful rate of sample preparation was high after the firing to remove the PU foams and 
sinter the remaining porous structures. However, the method resulted in large defects in the struts 
after the removal of the PU struts. This shortcoming could be overcome by repeated dipping in the 
CPC slurry, followed by sintering again. In addition, the applied PLGA–bioactive glass composite 
coating resulted in better mechanical properties and without the loss of bioactivity. Of course, other 
bioactive or biodegradable polymers could be used for the purpose of the current project. The 
porous and sintered CPC further coated with PLGA-bioactive glass could not be broken easily when 
thrown on the ground and could also tolerate the actions of cutting with a diamond grit-impregnated 
blade. In terms of mechanical properties (see Table 1) and bioactivity, the currently prepared porous 
bioactive/ biodegradable composites would be useful as bone tissue engineering scaffolds for non- 
or low loading bearing applications. 
 
 
4.  Conclusions 
 
Porous hydroxyapatite-based calcium phosphate ceramics with macropores sizes of about 2.0mm - 
0.7mm and micropore sizes of about 5µm were prepared by firing calcium phosphate cement coated 
on the struts of polyurethane foams at 1200ºC for 2 hours. The calcium phosphate cement was 
prepared at room temperature by mixing tetracalcium phosphate (Ca4(PO4)2O) and dicalcium 
phosphate anhydrous (CaHPO4) powders with sodium phosphate (Na2HPO4) solution. The 
tetracalcium phosphate was prepared by firing the mixture of pyro-calcium phosphate (Ca2P2O7) 
and calcium carbonate (CaCO3) at 1350ºC for 5 hours, followed by quenching in air. The prepared 
porous hydroxyapatite-based ceramics exhibited high porosities and high pore interconnectivities.  
 
However, the mechanical strengths of the porous hydroxyapatite-based calcium phosphate samples 
were far too low (<< 1 MPa). After impregnating and coating with the bioactive glass (33 wt%)-
PLGA composite, the macropores of the sintered porous calcium phosphate (mainly 
hydroxyapatite) ceramics remained highly interconnected. The compressive strengths of the PLGA-
bioactive glass coated porous sintered calcium phosphates were also increased up to 7.7MPa. 
Finally, the coated porous calcium phosphate scaffolds could be trimmed by cutting actions and the 
bioactivity of the composite scaffolds was confirmed by the apatite layer formation in the simulated 
body fluid. 
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Figure captions 
 
Fig. 1  Stero-optical micrograph showing the pores (~1 mm) and the struts of a polymer foam. 
 
Fig. 2  Stero-optical micrograph showing the pores (~ 0.7mm) and the struts of the sintered porous 
calcium phosphate (mainly hydroxyapatite). 
 
Fig. 3  SEM micrograph of a fracture surface of a strut of the sintered porous calcium phosphate 
(mainly hydroxyapatite). 
 
Fig. 4  XRD pattern for a sintered porous calcium phosphate (mainly hydroxyapatite) sample. 
 
Fig. 5  Bioactive glass-PLGA coating on the sintered porous calcium phosphate with a medium pore 
size of 1.3mm. 
 
Fig. 6   SEM micrograph of a fractured surface of the microporous strut (mainly hydroxyapatite) 
filled with PLGA. 
 
Fig. 7  SEM micrograph of the 58S bioactive glass–PLGA coating on the sintered porous calcium 
phosphate (mainly hydroxyapatite). 
 
Fig. 8  SEM micrograph showing the apatite layer formed on the bioactive glass-PLGA coating 
after the immersion in SBF. 
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Fig. 1  Stero-optical micrograph showing the pores (~1 mm) and the struts of a polymer foam.    
 
 
 
 
 
Fig. 2  Stero-optical micrograph showing the pores (~ 0.7mm) and the struts of the sintered porous 
calcium phosphate (mainly hydroxyapatite).   
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Fig. 3  SEM micrograph of a fracture surface of a strut of the sintered porous calcium phosphate 
(mainly hydroxyapatite).   
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Fig. 4  XRD pattern for a sintered porous calcium phosphate (mainly hydroxyapatite) sample.  
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Fig. 5  Bioactive glass-PLGA coating on the sintered porous calcium phosphate with a medium pore 
size of 1.3mm.  
 
 
 
 
 
Fig. 6   SEM micrograph of a fractured surface of the microporous strut (mainly hydroxyapatite) 
filled with PLGA.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7  SEM micrograph of the 58S bioactive glass–PLGA coating on the sintered porous calcium 
phosphate (mainly hydroxyapatite).   
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Fig. 8  SEM micrograph showing the apatite layer formed on the bioactive glass-PLGA coating 
after the immersion in SBF.  
 
 
Table  
 
 
Table 1.  Comparison among the porous sintered CPC, the bioactive glass-PLGA coated porous 
sintered CPC, and cancellous (or spongy) bones. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Types of materials Macropore 
size 
(mm) 
Total 
porosity 
(%) 
Compressive 
strength 
(MPa) 
Compressive 
modulus 
(GPa) 
2.0 91 0.03 1.55 
1.3 86 0.09 1.90 
Porous sintered CPC 
0.7 75 0.20 2.22 
1.9  2.39 2.30 
1.2  2.56 2.47 
Bioactive glass-PLGA 
coated porous sintered 
CPC 0.6  7.70 3.20 
Cancellous bones 1-5  30-90 2-12 0.2–5  
